Insulin detemir and Mesalamine Controlled-Release Capsules
Determining the interaction of Insulin detemir and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin Detemir
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir-Mesalamine Delayed Release Tablets
- Insulin detemir-Mesalamine Long-Acting Capsules (Apriso)
- Insulin detemir-Mesalamine Long-Acting Capsules (Delzicol)
- Insulin detemir-Mesalamine Long-Acting Capsules (Pentasa)
- Insulin detemir-Mesalamine rectal
- Insulin detemir-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Insulin Detemir (Cartridges and Prefilled Syringes)
- Mesalamine Controlled-Release Capsules-Insulin Detemir (Vials)
- Mesalamine Controlled-Release Capsules-Insulin detemir Subcutaneous
- Mesalamine Controlled-Release Capsules-Insulin glargine
- Mesalamine Controlled-Release Capsules-Insulin Glargine (U-100) Cartridge Systems and Pens
- Mesalamine Controlled-Release Capsules-Insulin Glargine (U-100) Vials